<p>第三期開放獲取期刊展示了多學科心力衰竭研究及其對患者護理的多重影響。</p>
<p>, /PRNewswire/ -- _心臟衰竭交叉點期刊_一月刊彙集了新的分析和原創研究，探討心力衰竭護理如何通過創新管道、高風險生理狀態以及旨在實際應用的治療設計在實踐中取得進展。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>_心臟衰竭交叉點期刊_是一本開放獲取期刊，專注於心力衰竭及其與更廣泛心血管社區內其他學科和專業的各種交叉點。它是 JCF 期刊系列的一部分，也是美國心力衰竭學會的官方期刊之一。</p>
<p>本期的特色文章涵蓋了從開發到部署的整個過程。一項綜合評審詳細説明了風險投資和臨牀醫生主導的創業如何直接塑造現代心力衰竭的診斷和治療，使用如 mavacamten（MyoKardia）和可植入血流動力學監測等案例研究，説明醫學、科學和投資之間的合作如何轉化為患者影響。</p>
<p>補充這一系統層面的視角，原創研究發現外周靜脈動脈 ECMO 期間的新發房顫是顯著更高的拔管後死亡率的標誌，增強了在先進心力衰竭護理中一個脆弱轉折點的臨牀洞察。</p>
<p>另一項研究轉向處方行為本身，描述了一項離散選擇實驗的嚴格開發，旨在為 HFrEF 的多藥合劑未來臨牀試驗提供信息——將治療設計與臨牀醫生的優先事項和權衡對齊。通過量化藥物成分和特徵的權衡，該研究為未來的集羣隨機試驗奠定了基礎，併為尋求將治療設計與實際處方行為對齊的心血管研究人員提供了可複製的方法論路線圖。</p>
<p>這些文章共同反映了一個共同的主題：改善心力衰竭的結果不僅需要更好的治療，還需要更好的對齊——科學與系統、生理與過程、創新與採用之間的對齊。</p>
<p>在線查看完整期刊。</p>
<p>如需與作者進行採訪，請聯繫 Laura Poko，郵箱為 [email protected]。</p>
<p><strong>關於_心臟衰竭交叉點期刊_</strong></p>
<p>_心臟衰竭交叉點期刊_是一本開放獲取期刊，專注於心力衰竭及其與更廣泛心血管社區內其他學科和專業的各種交叉點。該期刊特別關注多學科合作如何影響患者護理。發表的論文將涵蓋原創研究者主導的工作、最前沿的綜述、專家觀點，包括全球視角的文章、早期職業和培訓生的聚焦文章，以及患者和患者合作伙伴的敍述。</p>
<p><strong>關於美國心力衰竭學會</strong></p>
<p>美國心力衰竭學會（HFSA）代表了來自美洲的心力衰竭專家首次組織的努力，旨在為所有對心功能、心力衰竭和充血性心力衰竭（CHF）研究和患者護理感興趣的人提供一個論壇。HFSA 的使命是通過合作、教育、創新、研究和倡導來改善和擴展心力衰竭護理。HFSA 的成員包括醫生、科學家、護士、護士執業者、藥劑師、培訓生、其他醫療工作者和患者。有關更多信息，請訪問 hfsa.org。</p>
<p><strong>媒體聯繫人</strong>：Laura Poko，301-798-4493，分機 226，[email protected]</p>
<p>來源：美國心力衰竭學會</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9REM2Nzk5MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwOTA4UFJfTkVXU19VU1BSX19fX19EQzY3OTkz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9REM2Nzk5MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwOTA4UFJfTkVXU19VU1BSX19fX19EQzY3OTkz"/></p>

<p>《心臟衰竭雜誌 - 交叉點》一月刊強調了通過創新和多學科研究在心臟衰竭護理方面的進展。該期刊包含了關於風險投資在診斷和治療中的影響分析、關於 ECMO 期間房顫的原創研究，以及針對多藥丸試驗的離散選擇實驗的發展。該雜誌強調了將治療設計與臨牀醫生優先事項對齊的重要性，以改善心臟衰竭護理中的患者結果</p>

<p><em>The third issue of the open-access journal showcases multidisciplinary heart failure research and the many intersections that shape patient care.</em></p>
<div class="lb-trans"><p>第三期開放獲取期刊展示了多學科心力衰竭研究及其對患者護理的多重影響。</p>
</div><p>, /PRNewswire/ -- The January issue of <em>Journal of Cardiac Failure-Intersections</em> brings together new analyses and original investigations that examine how heart failure care advances in practice through innovation pipelines, high-risk physiologic states, and the design of therapies intended for real-world use.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- _心臟衰竭交叉點期刊_一月刊彙集了新的分析和原創研究，探討心力衰竭護理如何通過創新管道、高風險生理狀態以及旨在實際應用的治療設計在實踐中取得進展。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>The Journal of Cardiac Failure - Intersections is an Open Access journal with a focus on heart failure and its various intersections with other disciplines and specialties within the broader cardiovascular community. It is part of the JCF Family of Journals and one of the official journals of the Heart Failure Society of America.</p>
<div class="lb-trans"><p>_心臟衰竭交叉點期刊_是一本開放獲取期刊，專注於心力衰竭及其與更廣泛心血管社區內其他學科和專業的各種交叉點。它是 JCF 期刊系列的一部分，也是美國心力衰竭學會的官方期刊之一。</p>
</div><p>Featured articles in this issue span the continuum from development to deployment. A comprehensive review details how venture capital and clinician-led entrepreneurship have directly shaped modern heart failure diagnostics and therapeutics, using case studies such as mavacamten (MyoKardia) and implantable hemodynamic monitoring to illustrate how collaboration across medicine, science, and investment translates into patient impact.</p>
<div class="lb-trans"><p>本期的特色文章涵蓋了從開發到部署的整個過程。一項綜合評審詳細説明了風險投資和臨牀醫生主導的創業如何直接塑造現代心力衰竭的診斷和治療，使用如 mavacamten（MyoKardia）和可植入血流動力學監測等案例研究，説明醫學、科學和投資之間的合作如何轉化為患者影響。</p>
</div><p>Complementing this systems-level perspective, original research identifies de novo atrial fibrillation during peripheral veno-arterial ECMO as a marker of significantly higher post-decannulation mortality, sharpening clinical insight at a vulnerable inflection point in advanced heart failure care.</p>
<div class="lb-trans"><p>補充這一系統層面的視角，原創研究發現外周靜脈動脈 ECMO 期間的新發房顫是顯著更高的拔管後死亡率的標誌，增強了在先進心力衰竭護理中一個脆弱轉折點的臨牀洞察。</p>
</div><p>Another study turns to prescribing behavior itself, describing the rigorous development of a discrete choice experiment designed to inform future clinical trials of a polypill for HFrEF - aligning therapeutic design with clinician priorities and tradeoffs. By quantifying tradeoffs around drug components and features, the study lays the groundwork for future cluster-randomized trials and offers a replicable methodological roadmap for cardiovascular researchers seeking to align therapy design with real-world prescribing behavior.</p>
<div class="lb-trans"><p>另一項研究轉向處方行為本身，描述了一項離散選擇實驗的嚴格開發，旨在為 HFrEF 的多藥合劑未來臨牀試驗提供信息——將治療設計與臨牀醫生的優先事項和權衡對齊。通過量化藥物成分和特徵的權衡，該研究為未來的集羣隨機試驗奠定了基礎，併為尋求將治療設計與實際處方行為對齊的心血管研究人員提供了可複製的方法論路線圖。</p>
</div><p>Together, these articles reflect a shared throughline: improving outcomes in heart failure requires not only better therapies, but better alignment—between science and systems, physiology and process, and innovation and adoption.</p>
<div class="lb-trans"><p>這些文章共同反映了一個共同的主題：改善心力衰竭的結果不僅需要更好的治療，還需要更好的對齊——科學與系統、生理與過程、創新與採用之間的對齊。</p>
</div><p>View the full issue online.</p>
<div class="lb-trans"><p>在線查看完整期刊。</p>
</div><p>For interviews with authors, please contact Laura Poko at [email protected].</p>
<div class="lb-trans"><p>如需與作者進行採訪，請聯繫 Laura Poko，郵箱為 [email protected]。</p>
</div><p><strong>About the <em>Journal of Cardiac Failure-Intersections</em></strong></p>
<div class="lb-trans"><p><strong>關於_心臟衰竭交叉點期刊_</strong></p>
</div><p>The <em>Journal of Cardiac Failure-Intersections</em> is an open-access journal with a focus on heart failure and its various intersections with other disciplines and specialties within the broader cardiovascular community. The journal has a special focus on how multidisciplinary partnerships impact patient care. Published papers will span original investigator-initiated work to state-of-the-art reviews, expert perspectives, including those with a global viewpoint, early career and trainee spotlight pieces, and patient and patient-partner narratives.</p>
<div class="lb-trans"><p>_心臟衰竭交叉點期刊_是一本開放獲取期刊，專注於心力衰竭及其與更廣泛心血管社區內其他學科和專業的各種交叉點。該期刊特別關注多學科合作如何影響患者護理。發表的論文將涵蓋原創研究者主導的工作、最前沿的綜述、專家觀點，包括全球視角的文章、早期職業和培訓生的聚焦文章，以及患者和患者合作伙伴的敍述。</p>
</div><p><strong>About the Heart Failure Society of America</strong></p>
<div class="lb-trans"><p><strong>關於美國心力衰竭學會</strong></p>
</div><p>The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers, and patients. For more information, visit hfsa.org.</p>
<div class="lb-trans"><p>美國心力衰竭學會（HFSA）代表了來自美洲的心力衰竭專家首次組織的努力，旨在為所有對心功能、心力衰竭和充血性心力衰竭（CHF）研究和患者護理感興趣的人提供一個論壇。HFSA 的使命是通過合作、教育、創新、研究和倡導來改善和擴展心力衰竭護理。HFSA 的成員包括醫生、科學家、護士、護士執業者、藥劑師、培訓生、其他醫療工作者和患者。有關更多信息，請訪問 hfsa.org。</p>
</div><p><strong>Media Contact</strong>: Laura Poko, 301-798-4493, ext. 226, [email protected]</p>
<div class="lb-trans"><p><strong>媒體聯繫人</strong>：Laura Poko，301-798-4493，分機 226，[email protected]</p>
</div><p>SOURCE Heart Failure Society of America</p>
<div class="lb-trans"><p>來源：美國心力衰竭學會</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9REM2Nzk5MyZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEwOTA4UFJfTkVXU19VU1BSX19fX19EQzY3OTkz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC67993&amp;Transmission_Id=202601210908PR_NEWS_USPR_____DC67993&amp;DateId=20260121"/></p>

09:08 ET
			
			
				January Issue of Journal of Cardiac Failure-Intersections Examines How Innovation, Advanced Mechanical Support, and Prescribing Design Are Reshaping Heart Failure Care

《心臟衰竭雜誌》一月刊——交叉點探討創新、先進機械支持和處方設計如何重塑心力衰竭護理